Haruhiko Yoshida mostly deals with Hepatocellular carcinoma, Internal medicine, Surgery, Gastroenterology and Radiology. The Hepatocellular carcinoma study combines topics in areas such as Hepatitis C virus, Hepatitis C, Catheter ablation, Carcinoma and Survival analysis. As part of one scientific family, Haruhiko Yoshida deals mainly with the area of Internal medicine, narrowing it down to issues related to the Pathology, and often Tumor marker.
His study looks at the relationship between Surgery and topics such as Radiofrequency ablation, which overlap with Survival rate. His Gastroenterology study combines topics from a wide range of disciplines, such as Hazard ratio, Immunology, Hepatitis and Risk factor. He has included themes like Cholecystitis, Pancreatic cancer and Magnetic resonance cholangiopancreatography in his Radiology study.
Haruhiko Yoshida focuses on Internal medicine, Gastroenterology, Hepatocellular carcinoma, Surgery and Radiology. His biological study deals with issues like Hepatitis C virus, which deal with fields such as Viral load. The study incorporates disciplines such as Fibrosis, Cancer and Risk factor in addition to Gastroenterology.
In his research, Catheter ablation is intimately related to Radiofrequency ablation, which falls under the overarching field of Hepatocellular carcinoma. In the subject of general Radiology, his work in Stent is often linked to In patient, thereby combining diverse domains of study. His Cancer research research includes elements of Carcinogenesis and microRNA.
Haruhiko Yoshida mainly investigates Internal medicine, Gastroenterology, Hepatocellular carcinoma, Surgery and Radiology. As part of the same scientific family, he usually focuses on Internal medicine, concentrating on Hepatitis C virus and intersecting with Viral load. His research in Gastroenterology intersects with topics in Fibrosis, Diabetes mellitus, Immunology and Genotype.
His work carried out in the field of Hepatocellular carcinoma brings together such families of science as Survival rate, Percutaneous, Radiofrequency ablation and Carcinoma. In his study, which falls under the umbrella issue of Radiofrequency ablation, Survival analysis is strongly linked to Catheter ablation. His studies deal with areas such as Multivariate analysis, Adverse effect and Cohort as well as Surgery.
His primary areas of investigation include Internal medicine, Hepatocellular carcinoma, Gastroenterology, Surgery and Radiofrequency ablation. His work on Hepatology, Fibrosis, Predictive value of tests and Pancreas as part of general Internal medicine study is frequently linked to Wave velocity, therefore connecting diverse disciplines of science. His work deals with themes such as Regulator, Carcinoma, Radiology and Key, which intersect with Hepatocellular carcinoma.
His Radiology study combines topics in areas such as Liver tumor, Complication and Colorectal surgery. His studies in Gastroenterology integrate themes in fields like Diabetes mellitus, Odds ratio, Oncology and Fatty liver. His study in Radiofrequency ablation is interdisciplinary in nature, drawing from both Adverse effect, Percutaneous, Liver transplantation and Catheter ablation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma
Kentaro Kojima;Akemi Takata;Charles Vadnais;Motoyuki Otsuka.
Nature Communications (2012)
Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan
Haruhiko Yoshida;Yasushi Shiratori;Mitsuhiko Moriyama;Yasuyuki Arakawa.
Annals of Internal Medicine (1999)
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.
Masao Omata;Laurentius A. Lesmana;Ryosuke Tateishi;Pei Jer Chen.
Hepatology International (2010)
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy
Yasushi Shiratori;Fumio Imazeki;Mitsuhiko Moriyama;Michitami Yano.
Annals of Internal Medicine (2000)
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
Ryosuke Tateishi;Shuichiro Shiina;Takuma Teratani;Shuntaro Obi.
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma
Shuichiro Shiina;Takuma Teratani;Shuntaro Obi;Shinpei Sato.
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
Shuichiro Shiina;Ryosuke Tateishi;Toru Arano;Koji Uchino.
The American Journal of Gastroenterology (2012)
Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography
Ryota Masuzaki;Ryosuke Tateishi;Haruhiko Yoshida;Eriko Goto.
Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.
Keiji Ogura;Shin Maeda;Masafumi Nakao;Takeshi Watanabe.
Journal of Experimental Medicine (2000)
Hepatocellular carcinoma with extrahepatic metastasis
Koji Uchino;Ryosuke Tateishi;Shuichiro Shiina;Miho Kanda.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: